WEKO3
インデックスリンク
アイテム
Intervention of dementia support team pharmacists and its effects for the proper use of rivastigmine
https://gifu-pu.repo.nii.ac.jp/records/14584
https://gifu-pu.repo.nii.ac.jp/records/145843ea3ae01-4602-4d06-a449-eebfb28d4e02
Item type | 研究室原著論文(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-07-09 | |||||
タイトル | ||||||
タイトル | Intervention of dementia support team pharmacists and its effects for the proper use of rivastigmine | |||||
タイトル | ||||||
タイトル | Intervention of dementia support team pharmacists and its effects for the proper use of rivastigmine | |||||
言語 | en | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
抄録 | ||||||
値 | Pharmacist participation in the medical team is expected in dementia care. We investigated the use of rivastigmine, the intervention of pharmacists for its proper use, and its effects. The number of prescription proposals from the dementia care team pharmacist to the doctor was 87, and the number of acceptances was 57. The content of the proposal was 31/52 for additions/changes (number of acceptances/number of proposals), 21/28 for dose increase, 3/4 for discontinuation of administration, 2/2 for usage changes, and 1/1 for others. In increasing the dose, the number of patients who increased the maintenance dose to 18 mg was significantly higher in the group with the intervention of the pharmacist in the dementia care team than in the group without the intervention (3/12 cases vs. 0/24 cases, p = 0.031). The dose of the brought-in drug also significantly increased with pharmacist intervention compared with that in the non-intervention group (7/12 cases vs. 1/24 cases, p <0.001). The pharmacists of the dementia care team often intervened in the proper use of rivastigmine, which was found to be effective when increasing the dose. Thus, we believe that the active participation of pharmacists is necessary in dementia medication. | |||||
書誌情報 |
Die Pharmazie en : Die Pharmazie 巻 76, 号 7, p. 334-337, 発行日 2021-07 |
|||||
DOI | ||||||
値 | 10.1691/ph.2021.1534 |